CORT
Corcept Therapeutics
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CORT
- PE Ratio
As at Jul 24, 2026, the CORT stock has a price-to-earnings ratio of 207.3. This is based on the current EPS of $0.46 and the stock price of $95.36 per share. An increase of 212% has been recorded in the PE ratio compared to the average of 66.4 of the past four quarters.
CORT PE ratio history
The mean historical PE ratio of Corcept Therapeutics over the last ten years is 37.84. The current 207.3 price-to-earnings ratio is 448% more than the historical average. In the past ten years, CORT's PE ratio reached its highest point in the Sep 2016 quarter at 162.5, with a price of $6.5 and an EPS of $0.04. The Sep 2018 quarter saw the lowest point at 10.54, with a price of $14.02 and an EPS of $1.33.
Corcept Therapeutics PE ratio by year
Maximum annual increase: 92.62% in 2020
Maximum annual decrease: -84.73% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 36.63 | -1.88% | $34.8 | $0.95 |
| 2024 | 37.33 | 17.24% | $50.39 | $1.35 |
| 2023 | 31.84 | 48.92% | $32.48 | $1.02 |
| 2022 | 21.38 | 4.75% | $20.31 | $0.95 |
| 2021 | 20.41 | -28.21% | $19.8 | $0.97 |
| 2020 | 28.43 | 92.62% | $26.16 | $0.92 |
| 2019 | 14.76 | -28.18% | $12.1 | $0.82 |
| 2018 | 20.55 | 29.73% | $13.36 | $0.65 |
| 2017 | 15.84 | -84.73% | $18.06 | $1.14 |
| 2016 | 103.71 | N/A | $7.26 | $0.07 |
| 2015 | N/A | N/A | $4.98 | -$0.06 |
| 2014 | N/A | N/A | $3 | -$0.31 |
| 2013 | N/A | N/A | $3.21 | -$0.46 |
| 2012 | N/A | N/A | $1.43 | -$0.41 |
| 2011 | N/A | N/A | $3.42 | -$0.39 |
Corcept Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 87.63 | 139.23% | $40.31 | $0.46 |
| Dec 2025 | 36.63 | -55.93% | $34.8 | $0.95 |
| Sep 2025 | 83.11 | 42.68% | $83.11 | $1 |
| Jun 2025 | 58.25 | -35.23% | $73.4 | $1.26 |
| Mar 2025 | 89.94 | 140.93% | $114.22 | $1.27 |
| Dec 2024 | 37.33 | 9.7% | $50.39 | $1.35 |
| Sep 2024 | 34.03 | 27.79% | $46.28 | $1.36 |
| Jun 2024 | 26.63 | 21.6% | $32.49 | $1.22 |
| Mar 2024 | 21.9 | -31.22% | $25.19 | $1.15 |
| Dec 2023 | 31.84 | 2.84% | $32.48 | $1.02 |
| Sep 2023 | 30.96 | 23.84% | $27.25 | $0.88 |
| Jun 2023 | 25 | 1.58% | $22.25 | $0.89 |
| Mar 2023 | 24.61 | 15.11% | $21.66 | $0.88 |
| Dec 2022 | 21.38 | -9.94% | $20.31 | $0.95 |
| Sep 2022 | 23.74 | 1.84% | $25.64 | $1.08 |
CORT Price vs fair value
CORT average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of CORT is above its 3, 5 and 10-year historical averages.
PE comparison
Corcept Therapeutics's P/E of 207.3 is above the Healthcare sector, the industry and its peers average.
CORT PE vs peers
When compared to its peer stocks LLY and JNJ, CORT's PE ratio is higher. Corcept Therapeutics's PE ratio is trading above the peer group average of 30.15.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BMY Bristol Myers Squibb Co | 17.39 | $126.79B |
| PFE Pfizer Inc | 18.73 | $139.86B |
| NVS Novartis AG | 23.27 | $294.63B |
| JNJ Johnson & Johnson | 30.17 | $634.77B |
| MRK Merck & Co Inc | 36.71 | $323.72B |
| BMRN Biomarin Pharmaceutical Inc | 42.38 | $11.47B |
| LLY ELI LILLY & Co | 42.43 | $1.13T |
| CORT Corcept Therapeutics Inc | 207.3 | $10.24B |
| MNKD Mannkind Corp | N/A | $1.28B |
Frequently asked questions
What is Corcept Therapeutics's PE ratio?
The price to earnings ratio for CORT stock is 207.3 as of Jul 24, 2026.
What is the 3-year average PE ratio for Corcept Therapeutics (CORT)?
Over the last 3 years, the average PE ratio for CORT stock is 48.93.
What is the 5-year average PE ratio for Corcept Therapeutics (CORT)?
Over the last 5 years, the average PE ratio for CORT stock is 37.95.
What is the highest PE ratio for CORT?
The current PE of 207.3 represents the highest historical value in the last ten years.
How does the current PE ratio for CORT compare to its historical average?
CORT's current price to earnings ratio is 448% above its 10-year historical average.
Why is Corcept Therapeutics's PE ratio so high?
CORT's PE ratio of 207.3 is considered high because the company's stock price is trading at a higher multiple of earnings.
How is CORT's PE ratio calculated (Corcept Therapeutics PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jul 24, 2026), Corcept Therapeutics's stock price is $95.36. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.46. Therefore, Corcept Therapeutics's price to earnings ratio for today is 207.3. PE RATIO(207.3) = STOCK PRICE($95.36) / TTM EPS($0.46)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.